The FASEB J:线粒体功能和黑色素瘤发生之间神秘关联

2015-01-08 佚名 生物谷

近日,一篇刊登在国际杂志the FASEB Journal上的研究论文中,来自纽卡斯尔大学的研究人员通过研究揭示了为何某些个体易患皮肤癌,以及个体皮肤色素的改变和皮肤癌发病之间的关联;研究人员还发现,个体机体细胞线粒体功能的改变和癌性皮肤细胞黑色素产生存在直接关联,而这种联系或许可以帮助开发治疗皮肤癌的新型靶向性疗法。 研究者Mark Birch-Machin博士指出,本文研究揭示了一种新的

近日,一篇刊登在国际杂志the FASEB Journal上的研究论文中,来自纽卡斯尔大学的研究人员通过研究揭示了为何某些个体易患皮肤癌,以及个体皮肤色素的改变和皮肤癌发病之间的关联;研究人员还发现,个体机体细胞线粒体功能的改变和癌性皮肤细胞黑色素产生存在直接关联,而这种联系或许可以帮助开发治疗皮肤癌的新型靶向性疗法。

研究者Mark Birch-Machin博士指出,本文研究揭示了一种新的关联,即参与人类皮肤生物能产生过程的蛋白质(比如复合物II)和皮肤色素沉着之间的关联,这就提示复合物II或许在通过活性氧(ROS)信号介导的偶联压力感应和细胞适应过程中扮演着重要的作用,同时该研究发现或许也将帮助研究人员开发治疗皮肤癌的新型疗法。

文章中,研究人员检测了三种类型的黑色素瘤细胞产生低水平、中等水平及高水平色素的能力,同时分析了细胞处于静息状态下活性氧和线粒体复合物II的功能,线粒体复合物II是一种线粒体能量产生蛋白链的组分;研究者发现,在黑色素较重的细胞中通过复合物II介导的ROS的产生的比率也相对较高,随后研究者通过提供酪氨酸来诱导颜色较轻及处于中等程度的黑色素瘤细胞产生更多的黑色素。

研究者表示,当同时增强线粒体复合物II的功能时,所有的黑色素瘤细胞都会表现出较高的黑色素产生水平,该研究阐明,尽管疗法后ROS会增加黑色素产生将近300%,但是随后这种黑色素瘤的产生水平会降低到一个基准水平。黑色素瘤可以通过涂抹防晒霜来预防,研究者指出,但是目前全世界很多人死于黑色素瘤,而本文研究也揭示了黑色素产生和线粒体中活性氧产生之间的关系,这对于后期开发治疗黑色素瘤的新型疗法将会带来非常大的帮助。

原始出处

Sarah Jayne Boulton and Mark A. Birch-Machin1.Impact of hyperpigmentation on superoxide flux and melanoma cell metabolism at mitochondrial complex II.The FASEB Journal.2014

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1677172, encodeId=a5d216e7172fb, content=<a href='/topic/show?id=d31ce7585bb' target=_blank style='color:#2F92EE;'>#线粒体功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77585, encryptionId=d31ce7585bb, topicName=线粒体功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92f027457982, createdName=xuruicheng, createdTime=Sun Mar 22 21:08:00 CST 2015, time=2015-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2057896, encodeId=0fa4205e896d1, content=<a href='/topic/show?id=3836e24819' target=_blank style='color:#2F92EE;'>#FAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7248, encryptionId=3836e24819, topicName=FAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=872f168, createdName=gracezdd, createdTime=Wed Aug 12 14:08:00 CST 2015, time=2015-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1680267, encodeId=1062168026e68, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86707, encryptionId=9e5c86e0712, topicName=色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343027846633, createdName=sunylz, createdTime=Mon Dec 14 21:08:00 CST 2015, time=2015-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558683, encodeId=7f5a155868395, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Sat Jan 10 00:08:00 CST 2015, time=2015-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1564692, encodeId=071915646923b, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Sat Jan 10 00:08:00 CST 2015, time=2015-01-10, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1677172, encodeId=a5d216e7172fb, content=<a href='/topic/show?id=d31ce7585bb' target=_blank style='color:#2F92EE;'>#线粒体功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77585, encryptionId=d31ce7585bb, topicName=线粒体功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92f027457982, createdName=xuruicheng, createdTime=Sun Mar 22 21:08:00 CST 2015, time=2015-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2057896, encodeId=0fa4205e896d1, content=<a href='/topic/show?id=3836e24819' target=_blank style='color:#2F92EE;'>#FAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7248, encryptionId=3836e24819, topicName=FAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=872f168, createdName=gracezdd, createdTime=Wed Aug 12 14:08:00 CST 2015, time=2015-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1680267, encodeId=1062168026e68, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86707, encryptionId=9e5c86e0712, topicName=色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343027846633, createdName=sunylz, createdTime=Mon Dec 14 21:08:00 CST 2015, time=2015-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558683, encodeId=7f5a155868395, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Sat Jan 10 00:08:00 CST 2015, time=2015-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1564692, encodeId=071915646923b, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Sat Jan 10 00:08:00 CST 2015, time=2015-01-10, status=1, ipAttribution=)]
    2015-08-12 gracezdd
  3. [GetPortalCommentsPageByObjectIdResponse(id=1677172, encodeId=a5d216e7172fb, content=<a href='/topic/show?id=d31ce7585bb' target=_blank style='color:#2F92EE;'>#线粒体功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77585, encryptionId=d31ce7585bb, topicName=线粒体功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92f027457982, createdName=xuruicheng, createdTime=Sun Mar 22 21:08:00 CST 2015, time=2015-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2057896, encodeId=0fa4205e896d1, content=<a href='/topic/show?id=3836e24819' target=_blank style='color:#2F92EE;'>#FAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7248, encryptionId=3836e24819, topicName=FAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=872f168, createdName=gracezdd, createdTime=Wed Aug 12 14:08:00 CST 2015, time=2015-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1680267, encodeId=1062168026e68, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86707, encryptionId=9e5c86e0712, topicName=色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343027846633, createdName=sunylz, createdTime=Mon Dec 14 21:08:00 CST 2015, time=2015-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558683, encodeId=7f5a155868395, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Sat Jan 10 00:08:00 CST 2015, time=2015-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1564692, encodeId=071915646923b, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Sat Jan 10 00:08:00 CST 2015, time=2015-01-10, status=1, ipAttribution=)]
    2015-12-14 sunylz
  4. [GetPortalCommentsPageByObjectIdResponse(id=1677172, encodeId=a5d216e7172fb, content=<a href='/topic/show?id=d31ce7585bb' target=_blank style='color:#2F92EE;'>#线粒体功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77585, encryptionId=d31ce7585bb, topicName=线粒体功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92f027457982, createdName=xuruicheng, createdTime=Sun Mar 22 21:08:00 CST 2015, time=2015-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2057896, encodeId=0fa4205e896d1, content=<a href='/topic/show?id=3836e24819' target=_blank style='color:#2F92EE;'>#FAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7248, encryptionId=3836e24819, topicName=FAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=872f168, createdName=gracezdd, createdTime=Wed Aug 12 14:08:00 CST 2015, time=2015-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1680267, encodeId=1062168026e68, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86707, encryptionId=9e5c86e0712, topicName=色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343027846633, createdName=sunylz, createdTime=Mon Dec 14 21:08:00 CST 2015, time=2015-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558683, encodeId=7f5a155868395, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Sat Jan 10 00:08:00 CST 2015, time=2015-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1564692, encodeId=071915646923b, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Sat Jan 10 00:08:00 CST 2015, time=2015-01-10, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1677172, encodeId=a5d216e7172fb, content=<a href='/topic/show?id=d31ce7585bb' target=_blank style='color:#2F92EE;'>#线粒体功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77585, encryptionId=d31ce7585bb, topicName=线粒体功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92f027457982, createdName=xuruicheng, createdTime=Sun Mar 22 21:08:00 CST 2015, time=2015-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2057896, encodeId=0fa4205e896d1, content=<a href='/topic/show?id=3836e24819' target=_blank style='color:#2F92EE;'>#FAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7248, encryptionId=3836e24819, topicName=FAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=872f168, createdName=gracezdd, createdTime=Wed Aug 12 14:08:00 CST 2015, time=2015-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1680267, encodeId=1062168026e68, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86707, encryptionId=9e5c86e0712, topicName=色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343027846633, createdName=sunylz, createdTime=Mon Dec 14 21:08:00 CST 2015, time=2015-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558683, encodeId=7f5a155868395, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Sat Jan 10 00:08:00 CST 2015, time=2015-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1564692, encodeId=071915646923b, content=<a href='/topic/show?id=e27610332666' target=_blank style='color:#2F92EE;'>#黑色素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103326, encryptionId=e27610332666, topicName=黑色素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=150614999302, createdName=cqlidoudou, createdTime=Sat Jan 10 00:08:00 CST 2015, time=2015-01-10, status=1, ipAttribution=)]

相关资讯

Cell:我国科学家开发了一项新技术有望阻断线粒体遗传病

复旦大学今天宣布,该校医学神经生物学国家重点实验室沙红英、朱剑虹课题组,联合安徽医科大学曹云霞教授团队等,在探索遗传性线粒体疾病治疗研究方面取得突破性进展。相关研究论文日前发表于《细胞》。 据专家介绍,线粒体是为细胞提供能量的细胞器,它具有自身的一套DNA(mtDNA),通过母亲的卵子传递给下一代。发生在卵子中的线粒体突变可能引起母系家族性疾病。这种突变会导致严重的问题,受影响的大多数是能量需求

Eur Heart J:高血压患者中线粒体损伤机制及治疗进展

高血压是一种慢性疾病,在全球范围内将近有10亿人受到其影响,并且,其影响的深度还呈逐渐升高的趋势。血压升高,对于心脏和其他器官有着远期的伤害,主要在于其并发症的发生。 高血压患者心肌线粒体很容易受到损伤,主要是线粒体结构,生物功能和稳态的改变。线粒体是细胞的主要供能者,大量分布于心、肾、脑,以及高血压患者主要靶器官的实质细胞中。这些膜结合细胞器不仅维持细胞呼吸,还包括调节细胞增殖、凋亡,产生活性

曾庆平:二甲双胍,为何能成为长寿灵丹?

二甲双胍(metformin)是著名的降糖药,主要用来治疗2型糖尿病,但它对非酒精性脂肪肝病及癌症等多种人类疾病也有潜在治疗效果。更神奇的是,二甲双胍像热量限制一样能够延长生物的寿命,这已在线虫、大鼠和小鼠中得到证实。如此说来,二甲双胍堪称“神药”、“仙丹”! 6月2日,Science Daily网站报道了《美国科学院院报》(PNAS)刚刚在线发表的一篇最新论文,揭示二甲双胍通过“线粒体低毒

J Virol:线粒体蛋白TSPO抑制HIV囊膜蛋白合成

中国农业科学院哈尔滨兽医研究所郑永辉研究团队近日在国际病毒学权威期刊上发表了有关抑制艾滋病病毒囊膜蛋白合成的新途径的论文,为抗艾滋病疫苗及药物研制提供了新思路。郑永辉研究团队的研究结果能够为解释艾滋病病毒囊膜蛋白不能高效表达机制提供线索,而且阐明了一种新型的抗病毒机制。艾滋病疫苗的研制是一个世界性难题,至今仍没有成功。其难点之一就是艾滋病病毒的囊膜蛋白在哺乳动物细胞中很难得到高效表达。早在上个世纪

PLoS One:线粒体其实是寄生细菌?

细胞中的线粒体其实是一种细菌 据国外媒体报道,目前,美国弗吉尼亚大学最新一项研究表明,首次发现早期寄生细菌可以对动物和植物提供能量,在细胞中作为能量寄生虫存在,对寄居体十分有益。研究人员使用新一代DNA序列技术解码18种细菌基因组,这些细菌是线粒体的近亲生物。 该研究报告发表在近期出版的《公共科学图书馆·综合》杂志上,它为简单细菌细胞如何被宿主细胞吞噬和最终成为线粒体的两个

Nature:机体如何选择性对抗病原菌

对于正在接受治疗的癌症和其他疾病患者来说,细菌感染可引起一些主要问题。在住院期间问题尤为严重,因为此时患者的免疫功能往往变弱。 更复杂的是,缓解或防止感染的抗生素,可能对生活在体内的健康有益菌(主要在肠道内)产生负面影响。如果微生物群——意指栖居于体内的所有微生物——失去平衡,就会使有害细菌处于支配地位,并产生抗生素耐药菌株。 鉴于此,对于澄清“身体如何对抗病原菌而不消灭良性细菌”